Viewing Study NCT00600366


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-02-25 @ 9:48 PM
Study NCT ID: NCT00600366
Status: COMPLETED
Last Update Posted: 2017-01-06
First Post: 2008-01-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: